Gene · 10514
Papers1,449
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,449
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Insufficiency of 40S ribosomal proteins, RPS26 and RPS25, negatively affects biosynthesis of polyglycine-containing proteins in fragile-X associated conditions. | Elife | 2025 | 40377206 | PubTator, text mining | PubMed |
| Rapid Identification of Esophageal Squamous Cell Carcinoma Biomarkers by MALDI-TOF MS Fingerprinting of Extracellular Vesicles. | Anal Chem | 2025 | 40326690 | PubTator, text mining | PubMed |
| A long journey to the discovery of nuclear receptor coactivator existence, physiology, pathology, and therapy. | J Biol Chem | 2025 | 40090583 | PubTator, text mining | PubMed |
| MYBBP1A‑mediated IGFBP4 promoter methylation promotes epithelial‑mesenchymal transition and metastasis through activation of NOTCH pathway in liver cancer. | Int J Oncol | 2025 | 39611481 | PubTator, text mining | PubMed |
| USP30-AS1 Suppresses Colon Cancer Cell Inflammatory Response Through NF-κB/MYBBP1A Signaling. | Inflammation | 2025 | 39503963 | PubTator, text mining | PubMed |
| A multiomics approach reveals RNA dynamics promote cellular sensitivity to DNA hypomethylation. | Sci Rep | 2024 | 39472491 | PubTator, text mining | PubMed |
| Development of biomarker signatures associated with anoikis to predict prognosis in patients with esophageal cancer: An observational study. | Medicine (Baltimore) | 2024 | 39465737 | PubTator, text mining | PubMed |
| Insights into Asparaginase Allergic Responses: Exploring Pharmacogenetic Influences. | Pharmaceutics | 2024 | 39339172 | PubTator, text mining | PubMed |
| Non-immune hydrops fetalis is associated with bi-allelic pathogenic variants in the MYB Binding Protein 1a (MYBBP1A) gene. | Clin Genet | 2024 | 39191491 | PubTator, text mining | PubMed |
| The nucleolar phase of signal recognition particle assembly. | Life Sci Alliance | 2024 | 38858088 | PubTator, text mining | PubMed |
| NAT10-mediated upregulation of GAS5 facilitates immune cell infiltration in non-small cell lung cancer via the MYBBP1A-p53/IRF1/type I interferon signaling axis. | Cell Death Discov | 2024 | 38762546 | PubTator, text mining | PubMed |
| Deciphering the Impact of Rare Missense Variants in EGFR-TKI-Resistant Non-Small-Cell Lung Cancer through Whole Exome Sequencing: A Computational Approach. | ACS Omega | 2024 | 38617633 | PubTator, text mining | PubMed |
| Identification and validation of the clinical prediction model and biomarkers based on chromatin regulators in colon cancer by integrated analysis of bulk- and single-cell RNA sequencing data. | Transl Cancer Res | 2024 | 38617504 | PubTator, text mining | PubMed |
| MYBBP1A is required for efficient replication and gene expression of herpes simplex virus 1. | Microbiol Immunol | 2024 | 38402407 | PubTator, text mining | PubMed |
| Evaluation of AR, AR-V7, and p160 family as biomarkers for prostate cancer: insights into the clinical significance and disease progression. | J Cancer Res Clin Oncol | 2024 | 38305916 | PubTator, text mining | PubMed |
| Regulation of Angiogenesis by Non-Coding RNAs in Cancer. | Biomolecules | 2024 | 38254660 | PubTator, text mining | PubMed |
| Mechanism-centric regulatory network identifies NME2 and MYC programs as markers of Enzalutamide resistance in CRPC. | Nat Commun | 2024 | 38191557 | PubTator, text mining | PubMed |
| Long noncoding RNAs as versatile molecular regulators of cellular stress response and homeostasis. | Hum Genet | 2024 | 37782337 | PubTator, text mining | PubMed |
| A Prognostic Model for Prostate Cancer Patients Based on Two DNA Damage Response Mutation-Related Immune Genes. | Cancer Biother Radiopharm | 2024 | 37610864 | PubTator, text mining | PubMed |
| Downregulated RBM5 Enhances CARM1 Expression and Activates the PRKACA/GSK3β Signaling Pathway through Alternative Splicing-Coupled Nonsense-Mediated Decay. | Cancers (Basel) | 2023 | 38201567 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10514/papers?page=2